Bank of America’s Gain Therapeutics GANX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $7.5K | Buy |
4,164
+62
| +2% | +$112 | ﹤0.01% | 6209 |
|
|
2025
Q1 | $7.84K | Buy |
4,102
+17
| +0.4% | +$32 | ﹤0.01% | 6114 |
|
|
2024
Q4 | $8.82K | Buy |
4,085
+501
| +14% | +$1.08K | ﹤0.01% | 6089 |
|
|
2024
Q3 | $6.38K | Buy |
3,584
+84
| +2% | +$150 | ﹤0.01% | 6043 |
|
|
2024
Q2 | $4.48K | Buy |
3,500
+125
| +4% | +$160 | ﹤0.01% | 6144 |
|
|
2024
Q1 | $12.7K | Buy |
+3,375
| New | +$12.7K | ﹤0.01% | 5949 |
|